Form 8-K - Current report:
SEC Accession No. 0001564590-19-009156
Filing Date
2019-03-25
Accepted
2019-03-25 16:30:22
Documents
8
Period of Report
2019-03-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - EXECUTIVE COMPENSATION xene-8k_20190319.htm 8-K 75854
2 EX-10.1 xene-ex101_90.htm EX-10.1 143604
3 EX-10.2 xene-ex102_91.htm EX-10.2 151644
4 EX-10.3 xene-ex103_92.htm EX-10.3 158782
5 EX-10.4 xene-ex104_128.htm EX-10.4 133419
6 EX-10.5 xene-ex105_127.htm EX-10.5 137862
7 EX-10.6 xene-ex106_126.htm EX-10.6 152400
8 EX-10.7 xene-ex107_125.htm EX-10.7 149689
  Complete submission text file 0001564590-19-009156.txt   1104455
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 19702990
SIC: 2834 Pharmaceutical Preparations